Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States)

Cancer Causes and Control

Volumn 7, Issue 3, 1996, Pages 322-327

  Farrow, Diana C ^a,b   Vaughan, Thomas L ^a,b  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Esophageal neoplasms; SEER data; Survival; United States

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; EARLY DIAGNOSIS; ESOPHAGUS CARCINOMA; HUMAN; PRIORITY JOURNAL; SURVIVAL; UNITED STATES;

ADENOCARCINOMA; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; AGED; BARRETT ESOPHAGUS; CARCINOMA IN SITU; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FORECASTING; GASTROESOPHAGEAL REFLUX; HUMANS; INCIDENCE; MALE; MASS SCREENING; NEOPLASM STAGING; POPULATION SURVEILLANCE; PROGNOSIS; RISK FACTORS; SEER PROGRAM; SEX FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 0029978656     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00052937     Document Type: Article

References (17)

1. Yang PC, Davis S. Incidence of cancer of the esophagus in the U.S. by histologic type. Cancer 1988; 61: 512-7.
2. Powell J, McConkey CC. The rising trend in oesophageal adenocarcinoma and gastric cardia. Eur J Cancer Prev 1992; 1: 265-9.
3. Blot WJ, Devesa SS, Fraumeni JF Jr. Continuing climb in rates of esophageal adenocarcinoma: an update [Letter]. JAMA 1993; 270: 1320.
4. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-9.
5. Vaughan TL, Davis S, Kristal A, et al. Obesity, alcohol and tobacco as risk factors for cancer of the esophagus: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomark Prev 1995; 4: 85-92.
6. Brown LM, Swanson CA, Gridley G, et al. Adenocarcinoma of the esophagus: role of obesity and diet. JNCI 1995; 87: 104-9.
7. Reid BJ. Barrett's esophagus and esophageal adenocarcinoma. Gastroenterol Clin N Am 1991; 20: 817-34.
8. Gloeckler Ries LA, Hankey BF, Edwards BD, eds. Cancer Statistics Review 1973-87. Bethesda, MD (USA): National Cancer Institute, 1990; DHHS Pub. No. (NIH)90-2789.
9. World Health Organization. International Classification of Diseases for Oncology, First Edition. Geneva, Switzerland: WHO, 1976.
10. Percy C, Van Holten V, Muir C, eds. International Classification of Diseases for Oncology, Second Edition. Geneva, Switzerland: World Health Organization, 1990.
11. Norusis MJ, SPSS Inc. SPSS for Windows. Advanced Statistics. Chicago, IL (USA): SPSS Inc., 1993.
12. Shambaugh EW, Weiss MA, Axtell LM, eds. Summary Staging Guide: Cancer Surveillance, Epidemiology, and End Results (SEER) Program. Bethesda, MD (USA): National Institutes of Health, 1977; Department of Health, Education, and Welfare. (DHEW) Pub. No. (NIH) 77-1448.
13. Sarr MG, Hamilton SR, Marrone GC, et al. Barrett's esophagus: Its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux. Am J Surg 1985; 149: 187-93.
14. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985; 313: 857-9.
15. Phillips RW, Wong RKH. Barrett's esophagus: natural history, incidence, etiology and complications. Gastroenterol Clin N Am 1991; 20: 791-816.
16. Streitz JM, Andrews CW, Ellis FH, et al. Endoscopic surveillance of Barrett esophagus - does it help? J Thorac Cardiovasc Surg 1993; 105(3): 393-8.
17. Provenzale D, Kemp JA, Arora S, Wong JB. A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol 1994; 89: 670-9.